Allie Pangallo, in Cleves, OH - Physician Assistant

Allie Pangallo, is a Physician Assistant based in Cleves, Ohio. Allie Pangallo is licensed to practice in * (Not Available) (license number ) and her current practice location is 8538 Strimple Rd, Cleves, Ohio. She can be reached at her office (for appointments etc.) via phone at (513) 263-0335.

NPI number for Allie Pangallo is 1407609688 and her current mailing address is 8538 Strimple Rd, Cleves, Ohio. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1407609688.

Contact Information

	Allie Pangallo,
	8538 Strimple Rd, Cleves, OH 45002-9780
	(513) 263-0335
	Not Available

Provider's Profile

Full Name	Allie Pangallo
Gender	Female
Speciality	Physician Assistant
Location	8538 Strimple Rd, Cleves, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1407609688
Provider Enumeration Date: 04/08/2024
Last Update Date: 04/08/2024

Medical Identifiers

Medical identifiers for Allie Pangallo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407609688	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
363A00000X	Physician Assistant	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Allie Pangallo is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Allie Pangallo, 8538 Strimple Rd, Cleves, OH 45002-9780 Ph: (513) 263-0335	Allie Pangallo, 8538 Strimple Rd, Cleves, OH 45002-9780 Ph: (513) 263-0335

News Archive

Maternal use of valproate during pregnancy increases risk of autism in offspring

Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA.

Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases

A retrospective case-control study of 21,008 women in Finland has found that those with intrahepatic cholestasis of pregnancy (ICP), an itchy skin condition when bile gets backed up in the liver, are significantly more likely to suffer other liver diseases later in life.

DTC grants eligibility status to Medisafe 1 Technologies

Medisafe 1 Technologies Corp., a developer of a U.S. patented technology that physically prevents unauthorized administration of prescription medications, announced today that the company has been granted eligibility status by the Depository Trust Company. The DTC provides banks, brokerage firms and other institutions with an efficient means of moving securities and settling trades electronically.

NIH awards DNASU $6.5M grant to expand Protein Structure Initiative-Materials Repository

Arizona State University's Biodesign Institute- is home to a rich trove of biological material. Known as DNASU, this growing storehouse-a sort of genetic Library of Congress-holds over 147,000 plasmids, (circular DNA samples that can be used to produce individual proteins), as well as full genome collections from numerous organisms and proteins associated with many leading human diseases.

Cancer clues from pregnant lizards

A compound produced by a pregnant lizard may provide important information on the origins and treatment of cancer in humans, according to zoologist Bridget Murphy from the School of Biological Sciences who discovered the protein, which is pivotal to the development of the lizard placenta.

Allie Pangallo, - Physician Assistant in Cleves, OH